Syringaresinol Diglucoside-d6 is the labelled analogue of Syringaresinol Diglucoside (S920055) which is an impurity of Syringin. Syringin have exhibited the ability to enhance glucose utilization and the lowering of plasma glucose level in rats suffering from insulin deficiency, suggesting that this chemical may be useful in the treatment of human diabetes